bioAffinity Technologies Inc. (BIAF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

bioAffinity Technologies ...

NASDAQ: BIAF · Real-Time Price · USD
2.61
-0.17 (-6.12%)
At close: Oct 03, 2025, 3:59 PM
2.61
0.00%
After-hours: Oct 03, 2025, 07:56 PM EDT

bioAffinity Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.27M 1.85M 2.21M 2.35M 2.4M 2.41M 2.21M 298.48K 19.74K 921.00 2.35K 1.15K 1.31K n/a n/a n/a n/a n/a
Cost of Revenue
1.02M 1.37M 1.56M 1.44M 1.41M 1.72M 1.67M 74.7K 1.23K 87.00 175.00 146.00 146.00 1.04K 794.00 1.19K 1.19K 1.64K
Gross Profit
252.88K 485.74K 645.43K 910.23K 989.94K 683.31K 548.5K 223.78K 18.5K 834.00 2.17K 1K 1.16K -1.04K -794 -1.19K -1.19K -1.64K
Operating Income
-2.52M -2.63M -2.95M -1.97M -2.09M -1.95M -2.34M -2.29M -1.78M -1.56M -1.62M -976K -684K -727K -660K -526K -530K -491K
Interest Income
2.02K 542.00 4.07K 2.23K 5.19K 6.13K 12.16K 27.19K 44.12K 38.65K 45.86K 3.00 277.00 571.00 400.00 19.00 n/a 5.00
Pretax Income
-4.03M -2.65M -2.97M -2M -2.1M -1.96M -2.37M -2.29M -1.74M -1.52M -1.67M -4.92M -88.05K -1.47M -5.58M -1.51M 1.48M -714K
Net Income
-4.06M -2.66M -2.97M -2M -2.11M -1.96M -2.37M -2.29M -1.74M -1.53M -1.67M -4.92M -88.05K -1.47M -5.58M -1.51M 1.48M -716K
Selling & General & Admin
2.21M 2.45M 2.92M 2.37M 2.47M 2.19M 2.21M 2.02M 1.4M 1.15M 1.19M 596.48K 349.41K 352.52K 289.62K 161.55K 242.62K 186.99K
Research & Development
440.65K 367.39K 518.19K 368.2K 402.43K 442.6K 528.17K 330.38K 370.38K 389.25K 197.25K 380.69K 335.87K 332.35K 370.13K 364.74K 286.95K 304.22K
Other Expenses
113.23K 292.61K 153.81K 150.8K 151.07K 4.51K -15.3K 57.57K 21.55K 21.68K 7.33K n/a n/a 404.19K n/a n/a n/a n/a
Operating Expenses
2.77M 3.11M 3.59M 2.88M 3.08M 2.63M 2.74M 2.44M 1.8M 1.56M 1.63M 977.16K 685.28K 727.04K 659.75K 526.29K 529.57K 491.21K
Interest Expense
10.46K 15.48K 25.05K 21.63K 22.25K 23.55K 25.32K 8.79K 1.36K 1.66K 96.7K 889.09K 399.26K 1.15M 638.03K 135.36K 116.92K 111.55K
Selling & Marketing Expenses
n/a n/a n/a n/a 2.22M n/a n/a n/a -21.55K n/a -110.07K n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.79M 4.48M 5.15M 4.32M 4.49M 4.35M 4.56M 2.59M 1.8M 1.56M 1.63M 977.31K 685.43K 727.04K 659.75K 526.29K 529.57K 491.21K
Income Tax Expense
28.98K 8.7K -23.3K 2.56K 5.42K 3.67K 2.29K 2.29K 4.59K 11.82K 2.16K 300.00 n/a 2.16K n/a n/a n/a 1.95K
Shares Outstanding (Basic)
800.72K 541.9K 413.07K 413.07K 379.63K 330.5K 308.17K 289.88K 284.02K 281.12K 279.38K 140.13K 89.8K 89.37K 89.2K 90.93K 90.93K 90.93K
Shares Outstanding (Diluted)
800.72K 541.9K 413.07K 413.07K 379.63K 330.5K 308.17K 289.88K 284.02K 281.12K 279.38K 140.13K 90.93K 90.93K 90.93K 90.93K 90.93K 90.93K
EPS (Basic)
-5.1 -4.8 -6.3 -4.8 -5.7 -6 -7.8 -7.8 -6 -5.4 -6 -35.1 -0.97 -16.2 -62.4 -17.1 16.20 -8.1
EPS (Diluted)
-5.1 -4.8 -6 -4.8 -5.7 -6 -7.8 -7.8 -6 -5.4 -6 -35.1 -0.97 -16.2 -61.2 -16.5 16.20 -7.8
EBITDA
-3.91M -2.48M -2.79M -1.82M -1.93M -1.78M -2.2M -2.22M -1.71M -1.5M -1.57M -4.02M 312.25K -726K -4.94M -1.38M 1.6M -601K
EBIT
-4.02M -2.64M -2.94M -1.98M -2.08M -1.94M -2.35M -2.28M -1.73M -1.52M -1.58M -4.03M 311.21K -727K -4.94M -1.38M 1.6M -603K
Depreciation & Amortization
113.23K 154.59K 153.63K 151.3K 151.07K 149.64K 148.79K 57.57K 21.55K 21.68K 7.33K 773.00 1.04K 1.04K 794.00 1.19K 1.19K 1.64K